Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.

COVID-19 MI microvascular dysfunction microvascular injury myocardial injury

Journal

European cardiology
ISSN: 1758-3764
Titre abrégé: Eur Cardiol
Pays: England
ID NLM: 101574780

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 18 05 2020
accepted: 30 05 2020
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 4 7 2020
Statut: epublish

Résumé

Over the past few months, health systems worldwide have been put to the test with the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though the leading clinical manifestations of the SARS-CoV-2 infection involve the respiratory tract, there is a non-negligible risk of systemic involvement leading to the onset of multi-organ failure with fatal consequences. Since the onset of COVID-19, patients with underlying cardiovascular disease have been at increased risk of poor clinical outcomes with higher death rates. Moreover, the occurrence of new-onset cardiac complications is not uncommon among patients hospitalised for COVID-19. Of importance, a significant portion of COVID-19 patients present with myocardial injury. Herein, the authors discuss the mechanisms leading to myocardial and microvascular injury in SARS-CoV-2 infection and their clinical implications.

Identifiants

pubmed: 32617121
doi: 10.15420/ecr.2020.22
pmc: PMC7325215
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e52

Informations de copyright

Copyright © 2020, Radcliffe Cardiology.

Déclaration de conflit d'intérêts

Disclosure: The authors have no conflicts of interest to declare.

Références

Eur Heart J. 2020 Jun 7;41(22):2070-2079
pubmed: 32391877
Circulation. 2020 Jun 23;141(25):2113-2116
pubmed: 32352306
Eur Heart J. 2020 Feb 14;41(7):879-881
pubmed: 31377808
JAMA Intern Med. 2020 Mar 13;:
pubmed: 32167524
Circulation. 2012 Feb 14;125(6):773-81
pubmed: 22219349
Arch Intern Med. 2002 May 13;162(9):1059-64
pubmed: 11996618
EuroIntervention. 2020 Jun 25;16(3):233-246
pubmed: 32404302
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219356
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
JACC Case Rep. 2020 May 1;:
pubmed: 32363351
Herz. 2020 May;45(3):230-232
pubmed: 32140732
Eur Heart J. 2020 May 14;41(19):1801-1803
pubmed: 32196087
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
JAMA Cardiol. 2020 Mar 25;:
pubmed: 32211816
JAMA. 2020 Feb 7;:
pubmed: 32031570
Heart. 2020 Jun;106(12):923-930
pubmed: 31924712
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093

Auteurs

Rocco A Montone (RA)

Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS Rome, Italy.

Giulia Iannaccone (G)

Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart Rome, Italy.

Maria Chiara Meucci (MC)

Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart Rome, Italy.

Filippo Gurgoglione (F)

Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart Rome, Italy.

Giampaolo Niccoli (G)

Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A Gemelli IRCCS Rome, Italy.
Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart Rome, Italy.

Classifications MeSH